Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 97, S20-S28
- https://doi.org/10.1016/j.rmed.2003.10.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthmaRespiratory Medicine, 2000
- Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthmaRespiratory Medicine, 2000
- Once-Daily Inhaled Corticosteroids in Mild to Moderate AsthmaDrugs, 1999
- Once-daily budesonide in mild asthmaRespiratory Medicine, 1998
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.Thorax, 1995
- CFCs, their Replacements, and the Ozone LayerJournal of Aerosol Medicine, 1995
- CFCs and inhalersThe Lancet, 1994
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- The Normal Range of Diurnal Changes in Peak Expiratory Flow Rates: Relationship to Symptoms and Respiratory DiseaseAmerican Review of Respiratory Disease, 1991